US equities close higher; Asian markets trade mixed
US stocks closed mostly higher on Wednesday, as investors digested economic data and the start of the United Kingdom’s divorce from the European Union.
Asian shares traded mixed on Thursday morning.
All GST bills passed in Lok Sabha for uniform taxation across India
With the Lok Sabha signing off on the last batch of bills on the goods and services tax (GST), India is just a step away from rolling out an indirect tax regime that will for the first time economically unify the country.
Supreme Court bans sale of BS-III vehicles after 1 April
The Supreme Court directed that vehicles that are not Bharat Stage-IV (BS-IV) compliant will not be sold after 31 March.
Tata Tigor launched, prices start at Rs4.7 lakh, ex-showroom Delhi
Tata Motors Ltd launched the Tigor sedan. With prices starting from Rs4.7 lakh to 6.19 lakh for the petrol version and Rs5.6 lakh to Rs7 lakh for diesel, (ex-showroom, Delhi) the company has positioned the new model, based on the Tiago platform, as a style back.
P&G moves Delhi HC in appeal against airing of ‘disparaging’ shampoo ads by HUL
Leading fast moving consumer goods (FMCG) company, Proctor & Gamble, on Wednesday moved the Delhi high court in appeal against an order dismissing its plea over alleged disparaging shampoo advertisements being aired by its competitor, Hindustan Unilever Ltd (HUL)
FIPB green lights Gland Pharma’s acquisition by Shanghai Fosun
The Foreign Investment and Promotion Board (FIPB) cleared Shanghai Fosun Pharmaceutical (Group) Co. Ltd’s $1.3 billion acquisition of Hyderabad-based Gland Pharma Ltd.
Lupin launches generic HIV drug in US market
Drug firm Lupin has launched generic Abacavir and Lamivudine tablets used for treatment of human immunodeficiency infection in the American market.
Daiichi asks court to appoint auditor to inspect Singh brothers’ documents
Japanese drugmaker Daiichi Sankyo Co. Ltd moved the Delhi High Court, seeking the appointment of a third-party auditor to assist in the inspection of documents submitted by brothers Malvinder and Shivender Singh, former owners of Ranbaxy Laboratories Ltd.
